Literature DB >> 17638820

Interferon alpha eye drops: treatment of atypical lymphoid hyperplasia with secondary alopecia.

P T Finger, D Reichstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17638820      PMCID： PMC1954790          DOI： 10.1136/bjo.2006.106930

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

Review 1.  Chemotherapy for eye cancer.

Authors:  M W Wilson; G Czechonska; P T Finger; A Rausen; M E Hooper; B G Haik
Journal:  Surv Ophthalmol       Date:  2001 Mar-Apr       Impact factor: 6.048

2.  Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.

Authors:  S Esquenazi; C L Fry; E Holley
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

4.  Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.

Authors:  Barry A Schechter; Amilia Schrier; Robert S Nagler; Edward F Smith; Gabriel E Velasquez
Journal:  Cornea       Date:  2002-01       Impact factor: 2.651

5.  Prognosis of orbital lymphoid hyperplasia.

Authors:  E Polito; A Leccisotti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

6.  Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C.

Authors:  G Taliani; E Biliotti; M Capanni; A Tozzi; S Bresci; N Pimpinelli
Journal:  J Chemother       Date:  2005-04       Impact factor: 1.714

7.  Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.

Authors:  Sarah E Coupland; Martin Hellmich; Claudia Auw-Haedrich; William R Lee; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

8.  Periocular lymphoproliferative diseases: natural history, prognostic factors, and treatment.

Authors:  B A Erickson; G J Harris; C A Enke; K J Murray; B M Massaro; G A Hanson; R M Hansen; T Anderson; J F Wilson
Journal:  Radiology       Date:  1992-10       Impact factor: 11.105

9.  Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.

Authors:  Michael D Boehm; Andrew J W Huang
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

10.  A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma.

Authors:  B Guillot; L Blazquez; D Bessis; O Dereure; J J Guilhou
Journal:  Dermatology       Date:  2004       Impact factor: 5.366
  10 in total
  2 in total

1.  [Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis].

Authors:  E Torres Suárez; R Pinheiro; N Schrage
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

2.  Bilateral benign reactive lymphoid hyperplasia of the conjunctiva: a case treated with oral doxycycline and review of the literature.

Authors:  Olga Klavdianou; Georgios Kondylis; Vasileios Georgopoulos; Sotiria Palioura
Journal:  Eye Vis (Lond)       Date:  2019-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.